Don’t panic over Ebola. But don’t ignore it, either. That was the take-home message for U.S. citizens from a “mini-hearing” held by U.S. Sen. Lamar Alexander, R-Tenn., at Vanderbilt University Medical Center on Wednesday with researchers and health officials from Vanderbilt and the State of Tennessee.

Don’t panic over Ebola. But don’t ignore it, either. That was the take-home message for U.S. citizens from a “mini-hearing” held by U.S. Sen. Lamar Alexander, R-Tenn., at Vanderbilt University Medical Center on Wednesday with researchers and health officials from Vanderbilt and the State of Tennessee.

Vanderbilt University researchers have partnered with Mapp Biopharmaceutical Inc. to develop new human antibody therapies for people exposed to the deadly Ebola and Marburg viruses.

Drugs developed at Vanderbilt could provide a new way to treat schizophrenia in a personalized way.

During presentations that were filled with messages about Vanderbilt University Medical Center’s purpose, addressing the “why” rather than detailing facts and figures, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the School of Medicine, and C. Wright Pinson, MBA, M.D., deputy vice chancellor for Health Affairs and CEO of the Vanderbilt Health System, led the audience at Wednesday’s Fall Leadership Assembly through candid dialogue about VUMC’s way forward.